FAU.de
Deutsch
Login
Home
Publications
Research Grants
Inventions & Patents
Awards
Additional Research Activities
Faculties & Institutions
Research Areas
Dr. Katja Geßner
List of publications:
BibTeX-Download
Lehrstuhl für Klinische Pharmakologie und Klinische Toxikologie
Award(s)
(1)
Publications
(17)
Types of publications
Toggle all
Journal article
Journal article
Book chapter / Article in edited volumes
Book chapter / Article in edited volumes
Authored book
Authored book
Translation
Translation
Thesis
Thesis
Edited Volume
Edited Volume
Conference contribution
Conference contribution
Other publication type
Other publication type
Unpublished / Preprint
Unpublished / Preprint
Publication year
From
To
Abstract
Journal
Filters (inactive)
The Randomized AMBORA Trial: Impact of Pharmacological/Pharmaceutical Care on Medication Safety and Patient-Reported Outcomes During Treatment With New Oral Anticancer Agents (2021)
Dürr P, Schlichtig K, Kelz C, Deutsch B, Maas R, Eckart MJ, Wilke J, et al.
Journal article
Medication Errors During Treatment with New Oral Anticancer Agents: Consequences for Clinical Practice Based on the AMBORA Study (2021)
Schlichtig K, Dürr P, Dörje F, Fromm M
Journal article
Unanswered Questions Reply (2020)
Schlichtig K
Journal article, Letter
New Oral Anti-Cancer Drugs and Medication Safety (2019)
Schlichtig K, Duerr P, Dörje F, Fromm M
Journal article, Review article
Medication safety of new oral antitumor agents: a randomized trial on the impact of a clinical pharmacological / pharmaceutical intervention on drug-related problems and patient safety (2019)
Schlichtig K, Duerr P, Dörje F, Fromm F
Conference contribution
Medication safety in patients treated with new oral antitumor agents: a prospective, randomized investigation on the impact of intensified clinical pharmaceutical/ clinical pharmacological care on patient safety and well-being (AMBORA-Study - supported by the German Cancer Aid (70112447)) (2019)
Duerr P, Schlichtig K, Dörje F, Fromm M
Conference contribution
Medication safety in patients treated with new oral antitumor agents: A prospective, randomized investigation on the impact of intensified clinical pharmaceutical/clinical pharmacological care on patient safety, patient knowledge and patient well-being (AMBORA). Supported by the German Cancer Aid within the Comprehensive Cancer Center Erlangen-EMN (2018)
Schlichtig K, Lechner P, Grafe C, Ferstl B, Fuchs F, Hein A, Meidenbauer N, et al.
Conference contribution
‹
1
2
›